Company: IMNN
Filing Date: 2025-05-30
Form Type: PRE 14A
Source: 0001641172-25-013068
Chunk: 43

Company: Imunon, Inc.
Filing Date: 2025-05-30
Form: PRE 14A
Chunk 43
---
 No. 2. No broker non-votes are expected to exist in connection with this vote, as ratification of the independent registered public accounting firm is considered a routine matter under applicable rules, but any broker non-votes would have no effect on Proposal No. 2.

<div align='center'>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS A VOTE “FOR” THE PROPOSAL TO

RATIFY THE SELECTION OF WITHUM AS THE COMPANY’S INDEPENDENT REGISTERED

PUBLIC ACCOUNTING FIRM FOR THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2025.</div>

| 37 |

<div align='center'>PROPOSAL NO. 3:

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</div>

The Company is providing its stockholders with the opportunity to cast a non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed pursuant to the SEC’s executive compensation disclosure rules and set forth in this proxy statement (including in the compensation tables and narratives accompanying those tables).

Our executive compensation program is guided by the principle that the compensation of the Company’s executive officers should encourage the creation of stockholder value and achievement of strategic corporate objectives. In furtherance of this principle, the Company’s executive compensation program includes a number of features intended to reflect best practices in the market and help ensure that the program reinforces stockholder interests. These features include the following:

| ● | A                                                                                                                                  
 significant amount of the executives’ compensation is at risk. For fiscal year 2024, Approximately 30% of Dr. Lindborg’s           
 target total direct compensation was performance-based and/or linked to the value of the Company’s stock price.                    |
| ● | Executives’                                                                                                                        
 bonuses under our annual incentive program are principally based on the achievement of specific performance objectives established 
 at the beginning of the fiscal year by the Compensation Committee.                                                                 |
| ● | Executives’                                                                                                                        
 equity awards are granted in the form of stock options that help to align the executives’ interests with those of our stockholders 
 as the options will not have value unless there is appreciation in the Company’s stock price after the option is granted.          |

In accordance with the requirements of Section 14A of the Exchange Act (which was added by the Dodd-Frank Wall Street Reform and Consumer Protection Act) and the related rules of the SEC, the Board of Directors will request your advisory vote on the following resolution at the Annual Meeting